With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead ...

As biopharma and healthcare companies face a rapidly shifting regulatory environment, marketing and advisory firm Avalere ...

Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it ...

Built into the 2026 guidance is a $1.5 billion decline in sales of its COVID products—from an estimated $6.5 billion this ...

Fosun Pharma is spending 1.4 billion Chinese yuan ($200 million) to take on a 53% stake in Green Valley Pharmaceuticals and ...